Results 121 to 130 of about 21,829 (156)

Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis. [PDF]

Clin Infect Dis
Gatti M, De Paola R, Giorgi B, Pea F.
europepmc   +1 more source

Ceftazidime-Avibactam-Induced Neurotoxicity Manifesting as Seizure in an Older Adult: A Case Report. [PDF]

Infect Drug Resist
Li Z, Li C, Zhao P, Han Y, Lu N.
europepmc   +1 more source

Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: a retrospective study. [PDF]

Front Pharmacol
Qian S, Xu D, Xu Y, Qi H, Liang P.
europepmc   +1 more source

Emergence of ceftazidime-avibactam resistance mediated by KPC variants KPC-71 and KPC-78 in ST463 <i>Pseudomonas aeruginosa</i>. [PDF]

Microbiol Spectr
Yang F, Sun Y, Chen W, Shen D, Zhu J, Sun Z, Cai Y, Zhang Y, Shen H, Sun F, Xiao Y, Jiang C, Cui Z.   +12 more
europepmc   +1 more source

Hope Against Resistance: In Vitro Activity of the Ceftazidime-Avibactam and Aztreonam Combination Against Colistin-Resistant Klebsiella pneumoniae. [PDF]

Cureus
Mutha M, Subramani P, A R.
europepmc   +1 more source

Efficacy and safety of ceftazidime-avibactam in carbapenem-resistant gram-negative bacilli sepsis according to infection site. [PDF]

Am J Transl Res
Ru S, Ji F, Yang G, Xv H.
europepmc   +1 more source

Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections. [PDF]

Antimicrob Agents Chemother
Karaba SM, Hareza DA, Munita JM, Martinez JRW, Bergman Y, Hawes AM, Bulman ZP, Cosgrove SE, Simner PJ, Tamma PD.   +9 more
europepmc   +1 more source

Combating Carbapenem-Resistant <i>Enterobacterales</i>: Comparative <i>In Vitro</i> Efficacy of Aztreonam-Avibactam and Ceftazidime-Avibactam and Distribution of Carbapenemase Genes. [PDF]

Antibiotics (Basel)
Yaşar Duman M, Kanat M, Tanrıverdi ES, Çilli F, Aydemir Ş.   +4 more
europepmc   +1 more source

Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam. [PDF]

Antimicrob Agents Chemother
Feng C.
europepmc   +1 more source

Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration. [PDF]

Eur J Hosp Pharm
Chen F, Ding H, Liu S, Chen Z, Tang L, Tong T.   +5 more
europepmc   +1 more source